With markets on the sideline for the U.S. inflation data, the S&P 500 and Nasdaq set record highs, while the DJIA fell off 220 points, or 0.5%. In Hong Kong, the HSI opened 212 points lower, or 0.8%, at 25,987. The HSCEI dropped 95 points, or 1%, to 9,232. The HSTECH dipped 57 points, or 1%, to 5,845.

The pharmaceutical sector plummeted, with SINO BIOPHARM (01177.HK)  +0.190 (+2.251%)    Short selling $305.96M; Ratio 24.102%   and WUXI APPTEC (02359.HK)  +2.100 (+1.934%)    Short selling $67.66M; Ratio 8.184%   opening down 6.7% and 7%, respectively. BEIGENE (06160.HK)  +5.100 (+2.632%)    Short selling $181.65M; Ratio 11.645%   , CSPC PHARMA (01093.HK)  +0.230 (+2.273%)    Short selling $334.75M; Ratio 21.172%   , and WUXI BIO (02269.HK)  +0.480 (+1.333%)    Short selling $221.70M; Ratio 14.908%   plunged over 9%, while HANSOH PHARMA (03692.HK)  +0.400 (+1.136%)    Short selling $32.58M; Ratio 4.274%   slumped 15%. The sell-off followed reports that White House officials are drafting an executive order to impose strict controls on China’s development of experimental treatments.

BABA-W (09988.HK)  +7.800 (+5.443%)    Short selling $5.60B; Ratio 21.604%   opened 1.3% lower at HKD140.9 after announcing plans to issue USD3.2 billion in zero coupon convertible senior notes. Ele.me, Alibaba’s food delivery platform, plans to phase out penalties for late deliveries and enhance rider benefits, while rival MEITUAN-W (03690.HK)  0.000 (0.000%)    Short selling $1.09B; Ratio 10.363%   opened 1.5% lower at HKD100.2. NIO-SW (09866.HK)  +2.220 (+4.837%)    Short selling $177.53M; Ratio 34.904%   dived 3.6% to HKD45.02 after proposing to issue up to 181.8 million Class A ordinary shares priced at HKD43.36 each.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-09-12 16:25.)